← Back to Search

Behavioural Intervention

SinuSonic for Sinus Headache

Led By Amar Miglani, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Facial pain or pressure for > 3 months of symptom duration.
Pain/pressure VAS score of > 5.
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial is testing a new device to see if it can relieve facial pain and pressure better than a placebo device.

Eligible Conditions
  • Facial Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
You have had constant facial pain or pressure for more than 3 months.
You are experiencing significant pain or pressure, rated higher than 5 on a scale.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Brief Pain Inventory Short Form
Change in facial pain
Secondary outcome measures
Change in nasal obstruction symptoms
Subjects reporting epistaxis
Subjects reporting pain with device use

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SinuSonic GroupExperimental Treatment1 Intervention
Subjects will use the SinuSonic device for 2 minutes twice daily for 8 weeks
Group II: Sham GroupPlacebo Group1 Intervention
Subjects will use the sham device for 2 minutes twice daily for 8 weeks

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,155 Previous Clinical Trials
3,533,951 Total Patients Enrolled
1 Trials studying Facial Pain
300 Patients Enrolled for Facial Pain
Amar Miglani, MDPrincipal InvestigatorMayo Clinic

Media Library

SinuSonic (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05479604 — N/A
Facial Pain Research Study Groups: SinuSonic Group, Sham Group
Facial Pain Clinical Trial 2023: SinuSonic Highlights & Side Effects. Trial Name: NCT05479604 — N/A
SinuSonic (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05479604 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions for patients in this trial?

"According to the website, this trial is no longer actively recruiting patients. The original posting date was December 1st, 2022 and the most recent update was on October 26th of the same year. There are 168 other trials that you might consider enrolling in."

Answered by AI
~52 spots leftby Feb 2025